Can a diabetes drug boost weight loss after teen bariatric surgery?

NCT ID NCT06575738

First seen Jun 27, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study looks at what happens to the body after bariatric surgery in people aged 12 to 24. It also tests whether adding semaglutide (a weekly injection) can help those who haven't lost enough weight 1 to 2 years after surgery. The goal is to understand why some respond better than others and to define success beyond just weight loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
semaglutide
What this could lead to
If it works, this could point toward a way to help teens who don't lose enough weight after bariatric surgery, improving long-term health outcomes.
What could go wrong
This is a small, early-phase study with only 40 participants. It's testing a combination of surgery and medication, so results may not apply to everyone, and side effects from semaglutide (like nausea or vomiting) are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADOLESCENT OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Body-Weight Trajectory Obesity obesity disorder Pediatric Obesity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Childrens Hospital Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.